CABA vs. MAZE
CABA (Cabaletta Bio, Inc.) and MAZE (Maze Therapeutics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, CABA returned 64.22% vs 81.99% for MAZE. At a 0.24 correlation, their price movements are largely independent.
Performance
CABA vs. MAZE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CABA achieves a 63.47% return, which is significantly higher than MAZE's -40.00% return.
CABA
- 1D
- -2.72%
- 1M
- -6.53%
- YTD
- 63.47%
- 6M
- 43.20%
- 1Y
- 64.22%
- 3Y*
- -31.52%
- 5Y*
- -18.46%
- 10Y*
- —
MAZE
- 1D
- 2.35%
- 1M
- -7.69%
- YTD
- -40.00%
- 6M
- -40.08%
- 1Y
- 81.99%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CABA vs. MAZE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CABA Cabaletta Bio, Inc. | 63.47% | -8.37% |
MAZE Maze Therapeutics, Inc | -40.00% | 159.75% |
Correlation
The correlation between CABA and MAZE is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2025 | 0.24 |
Fundamentals
CABA:
$401.05M
MAZE:
$1.34B
CABA:
-$1.85
MAZE:
-$2.63
CABA:
3.88
MAZE:
3.92
CABA:
$0.00
MAZE:
$0.00
CABA:
$148.00K
MAZE:
-$1.15M
CABA:
-$181.04M
MAZE:
-$126.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CABA vs. MAZE — Risk / Return Rank
CABA
MAZE
CABA vs. MAZE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cabaletta Bio, Inc. (CABA) and Maze Therapeutics, Inc (MAZE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CABA | MAZE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.59 | 0.92 | -0.33 |
Sortino ratioReturn per unit of downside risk | 1.76 | 1.94 | -0.18 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.27 | -0.07 |
Calmar ratioReturn relative to maximum drawdown | 1.39 | 1.55 | -0.16 |
Martin ratioReturn relative to average drawdown | 2.42 | 3.57 | -1.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CABA | MAZE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.59 | 0.92 | -0.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | 0.42 | -0.55 |
Drawdowns
CABA vs. MAZE - Drawdown Comparison
The maximum CABA drawdown since its inception was -96.63%, which is greater than MAZE's maximum drawdown of -53.14%. Use the drawdown chart below to compare losses from any high point for CABA and MAZE.
Loading charts...
Drawdown Indicators
| CABA | MAZE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.63% | -53.14% | -43.49% |
Max Drawdown (1Y)Largest decline over 1 year | -46.37% | -53.14% | +6.77% |
Max Drawdown (3Y)Largest decline over 3 years | -95.90% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -95.90% | — | — |
Current DrawdownCurrent decline from peak | -85.89% | -52.04% | -33.85% |
Average DrawdownAverage peak-to-trough decline | -59.66% | -20.12% | -39.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.65% | 23.02% | +3.63% |
Volatility
CABA vs. MAZE - Volatility Comparison
Cabaletta Bio, Inc. (CABA) has a higher volatility of 21.67% compared to Maze Therapeutics, Inc (MAZE) at 12.14%. This indicates that CABA's price experiences larger fluctuations and is considered to be riskier than MAZE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CABA | MAZE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.67% | 12.14% | +9.53% |
Volatility (6M)Calculated over the trailing 6-month period | 61.03% | 57.36% | +3.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 108.82% | 90.36% | +18.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.62% | 95.15% | +18.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 109.69% | 95.15% | +14.54% |
Dividends
CABA vs. MAZE - Dividend Comparison
Neither CABA nor MAZE has paid dividends to shareholders.
Financials
CABA vs. MAZE - Financials Comparison
This section allows you to compare key financial metrics between Cabaletta Bio, Inc. and Maze Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CABA and MAZE have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CABA has higher volatility (21.67%) compared to MAZE (12.14%). In terms of maximum drawdown, CABA dropped -96.63% vs MAZE's -53.14%.
MAZE currently has the higher Sharpe Ratio (0.92 vs 0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CABA and MAZE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer